Skip to main content

Address And Details

PO Box 55932 , Boston, MA 02205-5932
Fund Manager Andrew Acker
Manager Tenure 14 Years 7 Months

Strategy And Objective

Janus Henderson Global Life Sciences Fund seeks long-term growth of capital. The Fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the Fund s pursuit of companies with a life science orientation, the Fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the life sciences sector, which may include companies in the following industry groups: pharmaceutical; biotechnology; health care services; and medical devices. Generally speaking, the life sciences relate to maintaining or improving quality of life. So, for example, companies with a life science orientation include companies engaged in research, development, production, or distribution of products or services related to health and personal care, medicine, or pharmaceuticals. The Fund implements its investment policies by investing primarily in equity securities of U.S. and foreign companies selected for their growth potential. The Fund normally invests in issuers from several different countries, which may include the United States. The Fund may, under unusual circumstances, invest in a single country. The Fund may have exposure to emerging markets. The Fund may invest in shares of companies through initial public offerings. The portfolio manager applies a bottom up approach in choosing investments. In other words, the portfolio manager looks at companies one at a time to determine if a company is an attractive investment opportunity and if it is consistent with the Fund s investment policies. The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time of the loan origination.

Net Asset Value

as of 6:03 PM ET 12/06/2021

Performance

  • 1 Week
  • -1.40%
  • 1 Month
  • -7.92%
  • 3 Months
  • -8.48%
  • 1 Yr Return
  • -4.28%
  • 5 Yr Return
  • +53.62%

Equity Sector Breakdown

Health 61.56%
Finance 10.49%
Services 9.82%
Technology 5.59%
IndustrialCyclical 5.52%
ConsumerDurables n/a
Energy n/a
NonDurables n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.42%
ForeignStocks 19.93%
Preferred 2.06%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 1.43 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.32 2.37 4.68
Beta 0.77 0.81 0.88
R Squared 0.72 0.69 0.54
Std Deviation 16.91 14.96 15.52
Sharpe Ratio 1.09 1.19 n/a

Purchase Information

as of 5:52 PM ET 12/03/2021
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $500

Performance

Timeframe Average Annual Current Performance Monthly As Of 11/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 11/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +4.83%
  • +17.78%
+4.83% +17.78%
3 Year
  • +13.76%
  • +13.21%
+13.76% +13.21%
10 Year
  • +17.87%
  • +19.19%
+17.87% +19.19%
Life Of Fund
  • +11.80%
  • +12.05%
+11.80% +12.05%

Top 10 Holdings

Symbol Company Name % Of Assets
AZN:LN ASTRAZENECA PLC 4.49%
UNH UNITEDHEALTH GROUP INC 3.97%
ROG ROCHE HOLDING AG 2.91%
ABBV ABBVIE INC 2.80%
MRK MERCK & CO 2.75%
NVS NOVARTIS AG ADR 2.58%
HUM HUMANA INC 2.46%
BSX BOSTON SCIENTIFIC CORP 2.45%
ABT ABBOTT LABORATORIES 2.29%
TMO THERMO FISHER SCIENTIFIC INC 2.28%

LATEST NEWS

Recent Articles from TheStreet

DocuSign Set for Strong Q3, RBC Says; Affirms Stock Outperform, Lifts Target

Buy the Dip: DocuSign, UnitedHealth, Stitch Fix

Recent stock market turbulence has tested investors' go-to trading tactic.

Cryptocurrency Operators Set For Consolidation In Fragmented Asian Market, Binance Says

CME Group Expands Crypto Suite with Micro Ether Futures

CME Group says Micro Ether 'is an efficient, cost-effective way for a range of market participant so hedge their spot Ether price risk.'

Pfizer CEO, Albert Bourla Lead

Pfizer CEO: Omicron Looks More Contagious, Less Dangerous

'I don’t think it’s good news to have something that spreads fast,' he said. 'Spreads fast means that it will be in billions of people.'

Coronavirus: Hong Kong Finance Chief Pushes For Lead Role In Global Supply Chain, Technology Amid Pandemic, But Economists Suggest City Ill-suited For The Task

Supply Chain Woes Will Ease in Q1, Analyst Says

Supply chain disruptions are expected to improve next year, including for the auto sector as chip availability may rise modestly.

Inflation-thumb

BofA Cites ETFs XLE, HDV, SCHD, VYM, Others as Inflation Fighters

The funds are 'buy-rated ETFs with above-market dividends and high exposure to inflation-protected sectors,' BofA said.

Video: Here's How Goldman Sachs May Change Under David Solomon

Goldman Sachs CEO Solomon: Many Markets Look Frothy

'I’m not a believer that double-digit equity returns compounding in perpetuity is something as an investor you should expect,' Goldman Sachs's CEO says.

After Instagram Co-Founders' Surprise Exit, a Veteran Facebook VP Could Step In

Instagram Attempts to Fix Safety Issues for Teens on Platform

Internal documents and research reveal that top executives at Meta knew about the harmful effects of Instagram on young girls.

Why Jim Cramer's Concerned About Facebook's Outage

Amazon, AWS Users Report Issues With Services

The AWS issue could have wide-ranging effects as different companies use Amazon servers for data storage.

Twitter Lead

Twitter Snaps Up Slack Competitor Quill In Bid to Own DMs

The details of the acquisition, particularly how much it cost, are not being made public.

13 wells fargo Roman Tiraspolsky : Shutterstock

Wells Fargo Borrower Defaults Creeping Higher, CEO Says

Wells Fargo is seeing 'very, very small amounts of delinquency increases,' Wells Fargo CEO Charles Scharf says. 'The bottom has been reached.'